MMSL 2025, 94(3):107-114 | DOI: 10.31482/mmsl.2024.009

CORRELATION OF COMORBIDITIES AND OUTCOME IN CAD PATIENTS: A NOVEL TANGENTS SCORE STUDYOriginal article

Mohammed Abdul Hannan Hazari ORCID...1, Kailas Laxman Rao ORCID...2, Bachi Tazneem3, Sana Rafeeq3*, Syeda Rahmath Fatima3, Summaya Jabeen3, Kankan Kavya3
1 Department of Physiology, Deccan College of Medical Sciences, DMRL ‘X’ Road, Kanchanbagh, Hyderabad-500058, Telangana, India
2 Department of Cardiology, Owaisi Hospital and Research Centre, Deccan College of Medical Sciences, DMRL ‘X’ Road, Kanchanbagh, Hyderabad-500058, Telangana, India
3 Deccan School of Pharmacy, Darussalam, Aghapura, Hyderabad-500001, Telangana, India

Background: Cardiovascular diseases (CVD) are influenced by various established risk factors, including the ratio of neutrophils to lymphocytes and platelets, which has been shown to be an independent risk factor for acute coronary syndrome (ACS). This study aims to create a new scoring system called TANGENTS that utilizes discrete parameters of risk factors and diagnostic parameters to analyze the outcome of coronary artery disease (CAD) patients with comorbidities, particularly Type 2 diabetes mellitus (T2DM).

Methods: We included 151 subjects (mean age 57.92 ± 23.86) who presented with ST-elevation and ST-depression on admission and were treated with heparin, clopidogrel, aspirin, and atorvastatin while undergoing all the necessary diagnostic tests. We obtained ECG and complete blood picture (CBP) results on admission, day 3, and day of discharge.

Results: ST-depression on ECG on day-1 was 0.35 and decreased to 0.30 on the day of discharge. ST-elevation on ECG on day-1 was -0.89 and decreased to -0.16 on the day of discharge. The average neutrophil-to-lymphocyte ratio (NPR) was 0.49, which was high in 144 patients. The mean NLR value was 5.52, indicating a correlation between high NLR values and the magnitude of current injury on admission.

Conclusion: The TANGENTS scoring system can be used as an early evaluation tool for CAD patients with comorbidities to manage and prevent further complications. It allows for progressive differentiation in the severity of clinical outcomes using all the parameters of the score, and the parameters creating the TANGENTS score scale were found to be reliable.

Keywords: TANGENTS Score; ECG (ST-Elevation And ST-Depression); Troponin-I, Stress Scoring Scale; Morisky Adherence Scale

Received: November 14, 2023; Revised: April 24, 2024; Accepted: May 2, 2024; Prepublished online: June 18, 2024; Published: September 1, 2025  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Hannan Hazari, M.A., Laxman Rao, K., Tazneem, B., Rafeeq, S., Fatima, S.R., Jabeen, S., & Kavya, K. (2025). CORRELATION OF COMORBIDITIES AND OUTCOME IN CAD PATIENTS: A NOVEL TANGENTS SCORE STUDY. MMSL94(3), 107-114. doi: 10.31482/mmsl.2024.009
Download citation

References

  1. Hussain MS, Sharma G. The Burden of Cardiovascular Diseases Due to COVID-19 Pandemic. The Thoracic and cardiovascular surgeon. 2022. Go to original source... Go to PubMed...
  2. Hussain MS, Afzal O, Gupta G, et al. Probing the links: Long non-coding RNAs and NF-κB signalling in atherosclerosis. Pathology, research and practice. 2023;249:154773. Go to original source... Go to PubMed...
  3. Somaschini A, Cornara S, Demarchi A, et al. Neutrophil to platelet ratio: A novel prognostic biomarker in ST-elevation myocardial infarction patients undergoing primary percutaneous coronary intervention. European journal of preventive cardiology. 2020;27(19):2338-2340. Go to original source... Go to PubMed...
  4. Demarchi A, Cornara S, Somaschini A, et al. Acute glycaemia in non diabetic patients with ST elevation myocardial infarction: could it be a direct mediator of myocardial damage? European Heart Journal. 2018;39:336. Go to original source...
  5. Bahl G, Upadhyay DK, Varma M, et al. Chronic Calcific Pancreatitis Presented with Secondary Diabetes and Diabetic Ketoacidosis: A Case Report. Clinical Diabetology. 2023. Go to original source...
  6. Bahl G, Hussain MS, Upadhyay DK, et al. Chronic Calcific Pancreatitis and Its Association With Secondary Diabetes Mellitus. 2023;13(3):89-95. Go to original source...
  7. Mahmood SS, Levy D, Vasan RS, et al. The Framingham Heart Study and the epidemiology of cardiovascular disease: a historical perspective. Lancet (London, England). 2014;383(9921):999-1008. Go to original source... Go to PubMed...
  8. Kaya H, Ertaº F, Soydinç MS. Association between neutrophil to lymphocyte ratio and severity of coronary artery disease. Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis. 2014;20(2):221. Go to original source... Go to PubMed...
  9. Brummett BH, Babyak MA, Mark DB, et al. Prospective study of perceived stress in cardiac patients. Annals of behavioral medicine : a publication of the Society of Behavioral Medicine. 2004;27(1):22-30. Go to original source... Go to PubMed...
  10. Naito R, Miyauchi K. Coronary Artery Disease and Type 2 Diabetes Mellitus. International heart journal. 2017;58(4):475-480. Go to original source... Go to PubMed...
  11. Rezende PC, Everett BM, Brooks MM, et al. Hypoglycemia and Elevated Troponin in Patients With Diabetes and Coronary Artery Disease. Journal of the American College of Cardiology. 2018;72(15):1778-1786. Go to original source... Go to PubMed...
  12. Jin P, Li X, Chen J, et al. Platelet-to-neutrophil ratio is a prognostic marker for 90-days outcome in acute ischemic stroke. Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia. 2019;63:110-115. Go to original source... Go to PubMed...
  13. Puri R, Nissen SE, Arsenault BJ, et al. Effect of C-Reactive Protein on Lipoprotein(a)-Associated Cardiovascular Risk in Optimally Treated Patients With High-Risk Vascular Disease: A Prespecified Secondary Analysis of the ACCELERATE Trial. JAMA cardiology. 2020;5(10):1136-1143. Go to original source... Go to PubMed...
  14. Hajar R. Risk Factors for Coronary Artery Disease: Historical Perspectives. Heart views : the official journal of the Gulf Heart Association. 2017;18(3):109-114. Go to original source... Go to PubMed...
  15. Andersson C, Vasan RS. Epidemiology of cardiovascular disease in young individuals. Nature reviews Cardiology. 2018;15(4):230-240. Go to original source... Go to PubMed...
  16. Bosomworth NJ. Practical use of the Framingham risk score in primary prevention: Canadian perspective. Canadian family physician Medecin de famille canadien. 2011;57(4):417-423.
  17. Conway Morris A, Caesar D, Gray S, et al. TIMI risk score accurately risk stratifies patients with undifferentiated chest pain presenting to an emergency department. Heart (British Cardiac Society). 2006;92(9):1333-1334. Go to original source... Go to PubMed...
  18. Kim MH, Kim YS, Oh HJ, et al. The Association between 10-Year Atherosclerotic Cardiovascular Diseases Risk Score Calculated Using 2013 American College of Cardiology/American Heart Association Guidelines and Serum 25-Hydroxyvitamin D Level among Aged 40-79 Years in Korea: The Sixth Korea National Health and Nutrition Examination Surveys. Korean journal of family medicine. 2018;39(3):174-179. Go to original source... Go to PubMed...
  19. Stary HC, Chandler AB, Dinsmore RE, et al. A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Circulation. 1995;92(5):1355-1374. Go to original source... Go to PubMed...